Biomarkers for the prediction of acute kidney injury: A narrative review on current status and future challenges

Clinical Kidney Journal

Volumn 5, Issue 2, 2012, Pages 102-108

  De Geus, Hilde R H ^a   Betjes, Michiel G ^a   Bakker, Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

AKI; biomarkers; ICU

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; FATTY ACID BINDING PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE P1; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; LIVER FATTY ACID BINDING PROTEIN; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; HUMAN; PHARMACEUTICAL CARE; PREDICTION; PRIORITY JOURNAL; REVIEW; UPREGULATION;

EID: 84873326279     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfs008     Document Type: Review

References (72)

1. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370 (Pubitemid 46179340)
2. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818 (Pubitemid 41175724)
3. Bagshaw SM, George C, Bellomo R. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 2007; 11: R68
4. Waikar SS, Curhan GC, Wald R et al. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006; 17: 1143-1150
5. Metnitz PG, Krenn CG, Steltzer H et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30: 2051-2058
6. Uchino S, Bellomo R, Bagshaw SM et al. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant 2010; 25: 1833-1839
7. Waikar SS, Betensky RA, Bonventre JV. Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 2009; 24: 3263-3265
8. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a metaanalysis. Am J Kidney Dis 2002; 40: 221-226 (Pubitemid 34827638)
9. Knight EL, Verhave JC, Spiegelman D et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421 (Pubitemid 38406982)
10. Okura T, Jotoku M, Irita J et al. Association between cystatin C and inflammation in patients with essential hypertension. Clin Exp Nephrol 2010; 14: 584-588
11. Fricker M, Wiesli P, Brandle M et al. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 2003; 63: 1944-1947 (Pubitemid 36513345)
12. Manetti L, Pardini E, Genovesi M et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 2005; 28: 346-349 (Pubitemid 43162754)
13. Manetti L, Genovesi M, Pardini E et al. Early effects of methylprednisolone infusion on serum cystatin C in patients with severe Graves' ophthalmopathy. Clin Chim Acta 2005; 356: 227-228 (Pubitemid 40779908)
14. Keller CR, Odden MC, Fried LF et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 2007; 71: 239-244 (Pubitemid 46160924)
15. Kos J, Stabuc B, Cimerman N et al. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 1998; 44: 2556-2557 (Pubitemid 28565678)
16. Nejat M, Pickering JW,Walker RJ et al. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant 2010; 25: 3283-3289
17. Herget-Rosenthal S, Marggraf G, Husing J et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-1122 (Pubitemid 39121017)
18. Royakkers AA, Korevaar JC, van Suijlen JD et al. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med 2011; 37: 493-501
19. Metzger J, Kirsch T, Schiffer E et al. Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury. Kidney Int 2010; 78: 1252-1262
20. Haase-Fielitz A, Bellomo R, Devarajan P et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med 2009; 37: 553-560
21. Koyner JL, Bennett MR, Worcester EM et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008; 74: 1059-1069
22. Borregaard N, Sehested M, Nielsen BS et al. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood 1995; 85: 812-817
23. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase- associated lipocalin from humans. Genomics 1997; 45: 17-23 (Pubitemid 27449379)
24. Friedl A, Stoesz SP, Buckley P et al. Neutrophil gelatinaseassociated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 1999; 31: 433-441
25. Flo TH, Smith KD, Sato S et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004; 432: 917-921 (Pubitemid 40037155)
26. Goetz DH, Holmes MA, Borregaard N et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002; 10: 1033-1043 (Pubitemid 36001971)
27. Yang J, Goetz D, Li JY et al. An iron delivery pathway mediated by a lipocalin. Mole Cell 2002; 10: 1045-1056 (Pubitemid 35453824)
28. Mishra J, Mori K, Ma Q et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004; 15: 3073-3082 (Pubitemid 39578839)
29. Fjaertoft G, Foucard T, Xu S et al. Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics. Acta Paediatr 2005; 94: 661-666 (Pubitemid 40839791)
30. Nielsen BS, Borregaard N, Bundgaard JR et al. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 1996; 38: 414-420
31. Shapiro NI, Trzeciak S, Hollander JE et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009; 37: 96-104
32. Xu SY, Pauksen K, Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 1995; 55: 125-131
33. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalinsiderophore- iron complex rescues the kidney from ischemiareperfusion injury. J Clin Invest 2005; 115: 610-621 (Pubitemid 40322235)
34. Hvidberg V, Jacobsen C, Strong RK et al. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinaseassociated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 2005; 579: 773-777
35. Schmidt-Ott KM, Mori K, Kalandadze A et al. Neutrophil gelatinase- associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006; 15: 442-449 (Pubitemid 44297988)
36. Schmidt-Ott KM, Mori K, Li JY et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007; 18: 407-413 (Pubitemid 46193306)
37. Siew ED, Ware LB, Gebretsadik T et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 2009; 20: 1823-1832
38. Cruz DN, de CalM, Garzotto F et al. Plasma neutrophil gelatinaseassociated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010; 36: 444-451
39. de Geus HR, Bakker J, Lesaffre EM et al. Neutrophil gelatinaseassociated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 2011; 183: 907-914
40. Martensson J, Bell M, Oldner A et al. Neutrophil gelatinaseassociated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 2010; 36: 1333-1340
41. Bagshaw SM, Bennett M, Haase M et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 2010; 36: 452-461
42. Koyner JL, Vaidya VS, Bennett MR et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010; 5: 2154-2165
43. McIlroy DR,Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010; 5: 211-219
44. Tuladhar SM, Puntmann VO, Soni M et al. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 2009; 53: 261-266
45. Perry TE, Muehlschlegel JD, Liu KY et al. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg 2010; 110: 1541-1547
46. Wagener G, Gubitosa G, Wang S et al. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis 2008; 52: 425-433
47. Liangos O, Tighiouart H, Perianayagam MC et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 2009; 14: 423-431
48. Endre ZH, Pickering JW, Walker RJ et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011; 79: 1119-1130
49. Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review andmeta-analysis. Am J Kidney Dis 2009; 54: 1012-1024
50. Ichimura T, Asseldonk EJ, Humphreys BD et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008; 118: 1657-1668 (Pubitemid 351632370)
51. Bailly V, Zhang Z, Meier W et al. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 2002; 277: 39739-39748 (Pubitemid 35190957)
52. Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 2009; 24: 3265-3268
53. Waanders F, Vaidya VS, van Goor H et al. Effect of reninangiotensin- aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Am J Kidney Dis 2009; 53: 16-25
54. Waanders F, van Timmeren MM, Stegeman CA et al. Kidney injury molecule-1 in renal disease. J Pathol 2010; 220: 7-16
55. Han WK, Waikar SS, Johnson A et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008; 73: 863-869 (Pubitemid 351398278)
56. Vaidya VS, Waikar SS, Ferguson MA et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 2008; 1: 200-208 (Pubitemid 352831522)
57. Liang XL, Liu SX, Chen YH et al. Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective nested case-control study. Biomarkers 2010; 15: 332-339
58. Ferguson MA, Vaidya VS, Waikar SS et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010; 77: 708-714
59. Oyama Y, Takeda T, Hama H et al. Evidence for megalinmediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Lab Invest 2005; 85: 522-531 (Pubitemid 40523944)
60. Yamamoto T, Noiri E, Ono Y et al. Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 2007; 18: 2894-2902 (Pubitemid 350058396)
61. Matsui K, Kamijo-Ikemori A, Hara M et al. Clinical significance of tubular and podocyte biomarkers in acute kidney injury. Clin Exp Nephrol 2011; 15: 220-225
62. Siew ED, Ikizler TA, Gebretsadik T et al. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol 2010; 5: 1497-1505
63. Parikh CR, Abraham E, Ancukiewicz M et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J AmSoc Nephrol 2005; 16: 3046-3052 (Pubitemid 44743502)
64. Herget-Rosenthal S, van Wijk JA, Brocker-Preuss M et al. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem 2007; 40: 946-951 (Pubitemid 47301786)
65. Nejat M, Hill JV, Pickering JW et al. Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplant 2011; doi: 10.1093/ndt/gfr222
66. Nejat M, Pickering JW, Walker RJ et al. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care 2010; 14: R85
67. Harrison DJ, Kharbanda R, Cunningham DS et al. Distribution of glutathione S-transferase isoenzymes in human kidney: basis for possible markers of renal injury. J Clin Pathol 1989; 42: 624-628 (Pubitemid 19156433)
68. Westhuyzen J, Endre ZH, Reece G et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003; 18: 543-551 (Pubitemid 36305660)
69. Walshe CM, Odejayi F, Ng S et al. Urinary glutathione Stransferase as an early marker for renal dysfunction in patients admitted to intensive care with sepsis. Crit Care Resusc 2009; 11: 204-209
70. Lameire NH, Vanholder RC, Van Biesen WA. How to use biomarkers efficiently in acute kidney injury. Kidney Int 2011; 79: 1047-1050
71. De Geus H, Le Noble J, Zijlstra F et al. Early predictive value of neutrophil gelatinase-associated lipocalin in adult ICU patients with acute kidney injury. Crit Care Med 2009: P255. Abstract
72. Endre ZH,Walker RJ, Pickering JW et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010; 77: 1020-1030